Added to YB: 2025-11-28
Pitch date: 2025-11-26
TECX [bullish]
Tectonic Therapeutic, Inc.
-13.92%
current return
Author Info
No bio for this author
Company Info
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs).
Market Cap
$397.7M
Pitch Price
$21.33
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.82
P/E
-5.48
EV/Sales
N/A
Sector
Biotechnology
Category
growth
Tectonic Therapeutic: Right Target, Right Patients, Realistic Expectations
TECX: TX45 relaxin-FC fusion targets cPCPH subset of HFpEF where both PCWP & PVR elevated. P1b showed -35.5% PVR drop but realistic P2 ceiling ~-25% due to receptor downregulation in diseased tissue. Expect +23m 6MWT gain vs 15-20m noise floor. 85% odds PVR endpoint success, 60% 6MWT win.
Read full article (9 min)